Cancer Therapy Due to Apoptosis: Galectin-9
Dysregulation of apoptosis is a major hallmark in cancer biology that might equip tumors with a higher malignant potential and chemoresistance. The anti-cancer activities of lectin, defined as a carbohydrate-binding protein that is not an enzyme or antibody, have been investigated for over a century...
Main Authors: | Koji Fujita, Hisakazu Iwama, Kyoko Oura, Tomoko Tadokoro, Eri Samukawa, Teppei Sakamoto, Takako Nomura, Joji Tani, Hirohito Yoneyama, Asahiro Morishita, Takashi Himoto, Mitsuomi Hirashima, Tsutomu Masaki |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-01-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/18/1/74 |
Similar Items
-
Human galectin-1 and galectin-3 promote Tropheryma whipplei infection
by: Diyoly Ayona, et al.
Published: (2021-01-01) -
The Sweet-Side of Leukocytes: Galectins as Master Regulators of Neutrophil Function
by: Brian S. Robinson, et al.
Published: (2019-08-01) -
Galectin-9 Induces Mitochondria-Mediated Apoptosis of Esophageal Cancer In Vitro and In Vivo in a Xenograft Mouse Model
by: Taiga Chiyo, et al.
Published: (2019-05-01) -
Intracellular galectins sense cytosolically exposed glycans as danger and mediate cellular responses
by: Ming-Hsiang Hong, et al.
Published: (2021-03-01) -
Targeting Galectins With Glycomimetics
by: Sara Bertuzzi, et al.
Published: (2020-08-01)